COVID-19 and cancer: a review of the registry-based pandemic response

A Desai, TJ Mohammed, N Duma, MC Garassino… - JAMA …, 2021 - jamanetwork.com
Importance The COVID-19 pandemic has had consequences for patients with cancer
worldwide and has been associated with delays in diagnosis, interruption of treatment and …

The impact of COVID-19 on cancer patients

D Wekking, TH Senevirathne, JL Pearce… - Cytokine & Growth …, 2023 - Elsevier
The COVID-19 pandemic poses a significant challenge for individuals with compromised
immune systems, such as patients with cancer, as they face a heightened susceptibility to …

Time-dependent COVID-19 mortality in patients with cancer: an updated analysis of the OnCovid registry

DJ Pinato, M Patel, L Scotti, E Colomba, S Dolly… - JAMA …, 2022 - jamanetwork.com
Importance Whether the severity and mortality of COVID-19 in patients with cancer have
improved in terms of disease management and capacity is yet to be defined. Objective To …

[HTML][HTML] Vaccination against SARS-CoV-2 protects from morbidity, mortality and sequelae from COVID19 in patients with cancer

DJ Pinato, D Ferrante, J Aguilar-Company… - European Journal of …, 2022 - Elsevier
Abstract Background Although SARS-CoV-2 vaccines immunogenicity in patients with
cancer has been investigated, whether they can significantly improve the severity of COVID …

[HTML][HTML] COVID-19 in patients with cancer: first report of the ESMO international, registry-based, cohort study (ESMO-CoCARE)

L Castelo-Branco, Z Tsourti, S Gennatas, J Rogado… - ESMO open, 2022 - Elsevier
Background ESMO COVID-19 and CAncer REgistry (ESMO-CoCARE) is an international
collaborative registry-based, cohort study gathering real-world data from Europe …

COVID-19 sequelae and the host proinflammatory response: an analysis from the OnCovid registry

A Cortellini, A Gennari, F Pommeret… - JNCI: Journal of the …, 2022 - academic.oup.com
Background Fifteen percent of patients with cancer experience symptomatic sequelae,
which impair post–COVID-19 outcomes. In this study, we investigated whether a …

[HTML][HTML] Neutrophil-to-lymphocyte ratio as a predictor of disease severity and mortality in coronavirus disease 2019: prospective study from Central India

BD Rathod, D Amle, RS Khot, KK Prathipati, PP Joshi - Cureus, 2022 - ncbi.nlm.nih.gov
Background: Clinical presentation of coronavirus disease 2019 (COVID-19) varies from an
asymptomatic state to severe disease characterized by acute respiratory distress syndrome …

Pandemic phase-adjusted analysis of COVID-19 outcomes reveals reduced intrinsic vulnerability and substantial vaccine protection from severe acute respiratory …

M Tagliamento, A Gennari, M Lambertini… - Journal of Clinical …, 2023 - ascopubs.org
PURPOSE Although representing the majority of newly diagnosed cancers, patients with
breast cancer appear less vulnerable to COVID-19 mortality compared with other …

[HTML][HTML] Survival and risk of COVID-19 after SARS-COV-2 vaccination in a series of 2391 cancer patients

P Heudel, B Favier, ML Solodky, S Assaad… - European Journal of …, 2022 - Elsevier
Background Patients with cancer are at high risk of severe or lethal COVID-19. The impact of
SARS-COV-2 vaccination on the risk of developing COVID-19 was investigated in an …

[HTML][HTML] Limited value of neutrophil-to-lymphocyte ratio and serum creatinine as point-of-care biomarkers of disease severity and infection mortality in patients …

A Tufa, TH Gebremariam, T Manyazewal, Y Asrat… - PLoS …, 2022 - journals.plos.org
Introduction In hospitalized COVID-19, neutrophil-to-lymphocyte ratio (NLR) and serum
creatinine is sometimes measured under assumption they predict disease severity and …